Corrigendum to "A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD" [Respir. Med. 120 November 2016 16-24]

Affiliations

• ¹ David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Electronic address: [email protected].
• ² Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
• ³ Servei de Pneumologia, Institut del Tòrax, Hospital Clínic-IDIBAPS-CIBERES, University of Barcelona, Barcelona, Spain.
• ⁴ Spartanburg Medical Research, Spartanburg, SC, USA.
• ⁵ Pulmonary Associates, Phoenix, AZ, USA.
• ⁶ Clinical Research of Rock Hill, Rock Hill, SC, USA.
• ⁷ New Horizons Clinical Research, Cincinnati, OH, USA.
• ⁸ University of North Carolina School of Medicine, Chapel Hill, NC, USA.
• ⁹ Pearl Therapeutics Inc., Morristown, NJ, USA.
• ¹⁰ Pearl Therapeutics Inc., Durham, NC, USA.